Cardiovascular disease (CVD) is the leading cause of death in men and women older than 65 years of age. This session looks at how hyperlipidemia, especially elevated low-density lipoprotein (LDL), is a major risk factor for CVD, and why older adults remain an under-recognized and under-treated high-risk population due to age-bias stemming from concerns regarding life expectancy, co-morbidity, safety of lipid lowering agents, and cost effectiveness of prevention.
Contact hours available until 9/20/2016.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, Authors, and Speakers Conflict of Interest Disclosure:
Debra Friedrich (session 162) discloses that she was a former speakers’ bureau member for Amarin.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
This educational activity has been co-provided by Anthony J. Jannetti, Inc. and GAPNA.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number, CEP 5387.
Objectives:
• Integrate research and treatment consensus for lipid-lowering in older adults.
• Utilize patient-centered care in the treatment of high cholesterol in the elderly.
• Apply appropriate cholesterol management strategies in the older adult (pharmacological and non-pharmacological).